Postoperatively, she rapidly recovered spontaneous respiration. Within minutes after extubation she developed acute respiratory failure followed by cardiovascular collapse. There was no evidence of further bleeding. She was rapidly reintubated and resuscitated, and on her return to the unit her girth had increased to 14 m and her abdomen was tympanic on percussion. Air was aspirated by suction on the Sengstaken tube and her cardiovascular system restabilised. She was extubated and returned to the ward.
Postoperatively, she rapidly recovered spontaneous respiration. Within minutes after extubation she developed acute respiratory failure followed by cardiovascular collapse. There was no evidence of further bleeding. She was rapidly reintubated and resuscitated, and on her return to the unit her girth had increased to 14 m and her abdomen was tympanic on percussion. Air was aspirated by suction on the Sengstaken tube and her cardiovascular system restabilised. She was extubated and returned to the ward. CASE 2 A 40 year old man with alcoholic liver disease was admitted after a massive haematemesis. Anaesthesia was induced with etomidate 10 mg and suxamethonium 100 mg and maintained with alcuronium 15 mg, 0 60," enflurane, oxygen, and 600,) nitrous oxide and intermittent positive pressure ventilation. At emergency endoscopy his varices were injected and a Sengstaken tube left in place.
Postoperatively, residual neuromuscular blockade was antagonised by atropine 1 2 mg and neostigmine 2-5 mg and spontaneous respiration returned. He was extubated in the left lateral position but, when turned on to his back, became apnoeic with circulatory collapse. He was again turned to the left lateral position, reintubated, and ventilated. Air was aspirated from the stomach via the Sengstaken tube and intermittent positive pressure ventilation was continued for two days before he could maintain adequate spontaneous respiration.
Discussion
Many abdominal conditions restrict diaphragmatic movement. These include simple obesity, pregnancy, ovarian cysts, and peritoneal dialysis, as well as ascites and gastric distension. Our two patients were already severely compromised by their ascites and the reduction in functional residual capacity that occurred in the supine position and after anaesthesia. Air insufflated by the endoscopist during variceal injection was retained in the stomach, which was already distended with the gastric balloon of the Sengstaken tube containing 400 ml air. This may have tipped these patients into acute respiratory failure. The clinical improvement after gastric decompression would tend to support this hypothesis. A pilot study investigating respiratory function in the presence of gross ascites has shown a reduction in vital capacity by up to 50",, of predicted values, and we propose to study this further.
High intra-abdominal pressures are known to reduce venous return and impair myocardial performance.2 The cardiovascular collapse seen in these two patients may have been due partly to compression of the inferior vena cava, the so called "supine hypotension syndrome" of pregnancy. Certainly the second patient (case 2) showed some clinical improvement when he was turned to the left lateral position before resuscitation.
Patients with ascites who undergo endoscopy should have all air aspirated at the end of the procedure, and careful respiratory supervision should be continued in an intensive care unit during the early postoperative phase. Introduction Brewers' yeast is sold as vitamin enriched tablets with added thiamine, riboflavine, and nicotinic acid. Although certain strains of yeast are known to accumulate porphyrins,l 2 there have been no reports of porphyrins in commonly taken vitamin enriched yeast tablets. Diagnosis of the porphyrias requires the routine identification and determination of porphyrins in blood, urine, and faeces. In recent years this has been carried out increasingly by high performance liquid chromatography. --6 We report a case of pseudoporphyria associated with consumption of brewers' yeast and describe the detailed analysis of porphyrins in these tablets and their relation to the biochemical identification of the porphyrias.
Present study CASE REPORT
A 24 year old man suffered persistently from episodic abdominal pain. Since no other abnormalities were found, screening tests for porphyrias were performed. He had normal urinary concentrations of 5-aminolaevulinate (15 limol/l (201 pig/100 ml); normal range 0-40 pimol,l (0-536 pg/100 ml)), porphobilinogen (1 6 /imol/l (36 ,lg/ 100 ml); normal range 0-8 limol/l (0-181 jig/100 ml)), and total porphyrins (85 Ig/l; normal range 50-250 ,ug/l). Results of haematological and serum biochemical studies including liver and renal function tests were normal. His erythrocyte hydroxymethylbilane synthase activity (32-6 nmol (27 jig) porphyrin/ml red cells/hour; normal range 20-42) was also normal. An acid solution of the faecal specimen, however, showed intense fluorescence typical of porphyrins. Detailed analysis of the faecal porphyrins by high performance liquid chromatography was therefore carried out resulting in the detection of raised concentrations of dicarboxylic porphyrins and coproporphyrin, together with a small amount of uroporphyrin. In addition, several unidentified fluorescent components not normally found in faecal porphyrin profiles' were detected.
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, was used. The dicarboxylic porphyrins were separated on a 15 cm 5 mm SAS-Hypersil column (5 jim spherical silica chemically bonded with trimethylsilyl groups) with 65", methanol in 1 0M ammonium acetate (pH 6-85) as the mobile phase. Uroporphyrins and coproporphyrins were analysed on a 25 cm x 5 mm ODSHypersil column (5 pm spherical silica chemically bonded with octadecylsilyl groups) eluted with 13o0 and 301" (vol/vol) acetonitrile in 1OM ammonium acetate buffer pH 5 15, respectively. Faecal porphyrin methyl esters were analysed as described. 3 Results Figure 1 shows the faecal porphyrin excretion patterns analysed as methyl esters by high performance liquid chromatography (a) of the patient consuming brewers' yeast tablets and (b) in a typical case of variegate porphyria. The dicarboxylic porphyrins (1 12 Itg/g dry weight; normal range 5-75) and coproporphyrin (68 /tg/g; normal range 5-50) of the patient were slightly but clearly increased. These findings together with his episodic abdominal pain suggested variegate porphyria. Nevertheless, the absence of dermatological symptoms, the normal urinary 5-aminolaevulinate and porphobilinogen concentrations, and the presence of other, unidentified compounds (peaks 3 and 5, fig 1) with ultraviolet absorption in the Soret region led us to suspect that these compounds-and possibly some of the porphyrins-might be of dietary origin. In addition, these unidentified compounds had not been observed in faecal profiles3 of patients with well defined porphyrias. The total amount of faecal porphyrins estimated spectrophotometrically (450 Itg/g dry weight) was also much higher than that measured by specific methods of high performance liquid chromatography. This again strongly indicated that much of the absorbance and fluorescence was not due to porphyrins. On close questioning the patient eventually admitted to ingesting more than 30 tablets (about 10 g) of brewers' yeast a day as part of a health diet. He was advised to stop the yeast tablets, and this was accompanied by a return to normal of his porphyrin excretion (fig 1 (c) Sample preparation-Powdered yeast tablets (0 5 g) in concentrated hydrochloric acid (2 ml) were sonicated in the dark for five minutes.
The mixture was then vortex mixed with 6 ml ether. Water (6 ml) was added and the mixture again vortex mixed. After centrifugation at 2000 g for 10 minutes the aqueous acid solution was used for porphyrin analysis by high performance liquid chromatography. Faecal specimens were similarly processed. It was important to establish that the excess porphyrins excreted by our patient were of brewers' yeast origin since they had resulted in a false positive diagnosis of porphyria. Furthermore, interpretation of porphyrin excretion patterns, which are used for the differential diagnosis of porphyrias, may be confused if a patient is concurrently taking yeast tablets. In order to analyse in detail the nature of porphyrins present in the yeast tablets a novel, highly efficient system of high performance liquid chromatography was developed for the separation of the dicarboxylic porphyrins. An SAS-Hypersil column with 6500 (vol/vol) methanol in 1 OM ammonium acetate completely resolved deuteroporphyrin, mesoporphyrin, and protoporphyrin (fig 2 (a) ). Figure 2 (b) shows the three dicarboxylic porphyrins present in the yeast tablet extract. Protoporphyrin was the main dicarboxylic porphyrin but a considerable amount of mesoporphyrin and a little deuteroporphyrin were also detected. The presence of deuteroporphyrin and mesoporphyrin was particularly interesting, as in man these are normally derived from protoporphyrin or protohaem by bacterial reduction in the gut. The total dicarboxylic porphyrin content was 9 2 Isg/g yeast tablet. The content of coproporphyrins was 6 0 ug/g yeast tablet and consisted of 60%o type I and 400) type III isomers (fig 3 (b) ). The uroporphyrins (0 25 ,ug/g yeast tablet) were present in much smaller quantities. The isomer composition was 55%<, type I and 45o type III (fig 4 (b) ).
Comment and conclusion
The results in our patient suggested that much of the excess porphyrins excreted in his faeces was of yeast tablet origin. In analyses of brewers' yeast tablets from different sources we found that these porphyrins were always present, although the quantities varied considerably. An intake of 10 g of yeast tablets corresponds to approximately 150 tg of porphyrins. The abdominal pain in our patient appeared to be associated with constipation, probably due to the irritable bowel syndrome rather than as a direct effect of the porphyrins. Stopping the yeast tablets led to rapid relief of symptoms.
Porphyrin profiles obtained by high performance liquid chromatography are undoubtedly useful for the differential diagnosis of the porphyrias and other porphyrinurias. When unusual porphyrin excretion patterns are observed a possible dietary origin of porphyrins must be investigated. Brewers' yeast tablets contain uroporphyrin, coproporphyrin, and dicarboxylic porphyrin, which may lead to misinterpretation of results.
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